|
Award Abstract #0215816
SBIR Phase II: High Rate Synthesis of Highly Reactive Solvated Metal Atom Dispersion Nanoparticles

| NSF Org: |
IIP
Division of Industrial Innovation and Partnerships
|
 |
 |
| Initial Amendment Date: |
July 12, 2002 |
 |
| Latest Amendment Date: |
July 12, 2002 |
 |
| Award Number: |
0215816 |
 |
| Award Instrument: |
Standard Grant |
 |
| Program Manager: |
Cheryl F. Albus
IIP Division of Industrial Innovation and Partnerships
ENG Directorate for Engineering
|
 |
| Start Date: |
July 15, 2002 |
 |
| Expires: |
June 30, 2004 (Estimated) |
 |
| Awarded Amount to Date: |
$499959 |
 |
| Investigator(s): |
Slawomir Winecki slawek@nanmatinc.com (Principal Investigator)
|
 |
| Sponsor: |
NANOSCALE MATERIALS INC
1310 RESEARCH PARK DR
MANHATTAN, KS 66502 785/537-0179
|
 |
| NSF Program(s): |
EXP PROG TO STIM COMP RES, SMALL BUSINESS PHASE II
|
 |
| Field Application(s): |
0308000 Industrial Technology
|
 |
| Program Reference Code(s): |
AMPP, 9163, 9150, 1415
|
 |
| Program Element Code(s): |
9150, 5373
|
ABSTRACT

This Small Business Innovation Research Phase II project focuses on the development and implementation of a Solvated Metal Atom Dispersion (SMAD) technique to support high rate production and commercial application of metal nanoparticle materials. Synthesis of gold and silver nanoparticle colloids for commercial use in the health care industry will be pursued as part of the proposed effort; the SMAD synthesis method will be optimized for commercial-scale manufacturing of gold and silver colloids. This approach yields high purity colloids, free of unwanted byproducts and ready for further processing without the cumbersome purification steps characteristic of other synthesis methods. This innovation significantly simplifies the manufacturing process of colloidal products and reduces production cost. The proprietary digestive-ripening step will be scaled up and developed to achieve monodispersion and particle size control of the metal nanoparticles contained in the colloids. Methods for transferring solvent-based colloids into an aqueous environment will be developed. Synthesis steps involved in the manufacturing of colloidal gold and silver will be integrated in a semi-continuous or continuous process.
The commercial potential of this project will be for immunological labeling and DNA detection using the colloidal gold solutions. The project offers an alternative-manufacturing route that significantly lowers the cost. Silver-based colloids have potential applications in burn wound treatment or as effective disinfectants and anti-inflammatory agents. The development of SMAD technology will enable high-volume manufacturing of many nanoparticle materials whose availability is currently limited by production inefficiencies. These nanomaterials will support future technologies in industry and find application in both commercial and academic research, as highly reactive catalytic materials, magnetic information storage media, ferrofluids, and magnetic tracers.
Please report errors in award information by writing to: awardsearch@nsf.gov.
|